Rheumatoid Arthritis Market

Global Market Study on Rheumatoid Arthritis Diagnosis Test: Commercialization of Novel Rapid Test Kits Underway

Rheumatoid Arthritis Market is segmented by Serology Tests, Erythrocyte Sedimentation Rate (ESR) through lens Loupes, Anti–cyclic Citrullinated Peptide (anti–CCP), Monitoring RA Treatment Efficiency Tests, Diagnostic Laboratories, Salicylate Level Count,

  • September-2019
  • PMRREP4788
  • 162 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Introduction

Rheumatoid arthritis (RA) is highly prevalent in North America and some European countries. According to the report published by Centre of Disease control and Prevention (CDC) in 2018, approximately 54 million adults suffered from rheumatoid arthritis in the U.S. Such high prevalence of RA requires effective diagnosis and treatment solutions. Thus, the rheumatoid arthritis diagnosis test market is expected to witness substantial growth in the global market in the forecast period.

Currently, the prevalence of rheumatoid arthritis is relatively low in developing countries. However, the rising number of geriatric population especially in China and Japan, is estimated to increase in the prevalence of rheumatoid arthritis in the forecast period.

This increasing prevalence of rheumatoid arthritis and other orthopedic disorders is expected to lead to a rise in demand for rheumatoid arthritis test kits across the Asia Pacific region, thus leading to the growth of the rheumatoid arthritis diagnosis test market.

global rheumatoid arthritis diagnosis test market

Find Out More about the Report Coverage

Companies

Company Profiles:

  • Abbott Diagnostics
  • Antibodies Incorporated
  • Beckman Coulter, Inc.
  • Euro Diagnostica AB
  • Thermo Fisher Scientific Inc. 
  • Qiagen NV
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthcare GmbH

Widespread Availability of Rheumatoid Arthritis Diagnostic Test Kits

Companies manufacturing rheumatoid arthritis diagnosis test kits are targeting the global market through their strong distribution network, thus making the product available at each level of value chain. Manufacturers are focusing on the distribution agreement and partnership with local distributors and manufacturing companies to cater to the increasing need for rheumatoid arthritis diagnosis test kits.

Currently, the rheumatoid arthritis diagnostic test market in the Asia Pacific region is being dominated by the off-label diagnosis procedures such as RF test, ESR test, uric acid test, and others, which have limited specificity and sensitivity. However, Anti–cyclic citrullinated peptide (anti–CCP) test and antinuclear antibody (ANA) test segments are anticipated to lead the market growth owing to their high specificity and sensitivity.

Thus, wide availability of these rheumatoid arthritis diagnosis test kits is propelling the growth of the rheumatoid arthritis diagnosis test market.

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Commercialization of Rapid Diagnostic Test Kits to Fuel the Market Growth

Increasing incidences of rheumatoid arthritis and other autoimmune diseases have created a need for rapid rheumatoid arthritis diagnostic test solutions, which would reduce the time and efforts required during sample testing.

Thus, rheumatoid arthritis diagnosis test kits manufacturers are focusing on the commercialization of novel rapid diagnostic test kits, which have high specificity and sensitivity.

The commercialization of rapid diagnostic test kits is anticipated to increase its demand as well as increase the efficacy of rheumatoid arthritis treatment monitoring test kits. The introduction of these rapid rheumatoid arthritis diagnosis test kits is contributing to the growth of the rheumatoid arthritis diagnosis test market.

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

Adoption of Minimally Invasive Rheumatoid Arthritis Diagnosis Test

There is a rise in incidences of rheumatoid arthritis among European and North American children. This increasing overall incidence rate, calls for adoption of minimally invasive test method to diagnose rheumatoid arthritis.

Hence, there is a high demand for rheumatoid arthritis diagnosis test kits with minimally invasive testing method in these regions, spurring the growth of the overall rheumatoid arthritis diagnosis test market.

Commercialization of cost effective drugs to treat rheumatoid arthritis is expected to promote the growth of the rheumatoid arthritis diagnosis test market, as these medications require continuous monitoring of patients. Moreover, it will help to promote the adoption of novel test methods used in the early diagnosis of rheumatoid arthritis. Hence, commercialization of drugs could have a direct impact on the growth of the rheumatoid arthritis diagnosis test market.

Explore Persistence Market Research’s expertise in promulgation of the business !

Analysts’ Viewpoint

A comprehensive view of the rheumatoid arthritis diagnosis test market has led our analysts to conclude that, the market is growing at an impressive rate, with Asia Pacific and Europe holding a large chunk of the global demand for rheumatoid arthritis diagnosis test kits. Increasing adoption of rheumatoid arthritis diagnosis test kits, especially in developed countries, such as the U.S, Mexico, and Germany, is spurring the growth of the global rheumatoid arthritis diagnosis test market.

The rheumatoid arthritis diagnosis test market is expected to have a robust growth in the forecast period in countries of the Latin American region.

This is attributed to the rising prevalence of rheumatoid arthritis among adult population in the region and also due to the improving healthcare facilities in countries such as Brazil and Mexico, thus contributing to the growth of the rheumatoid arthritis diagnosis test market.

Moreover, increasing demand for rapid rheumatoid arthritis diagnosis test kits is anticipated to create more opportunities for rheumatoid arthritis diagnosis test market players. In addition, the development of novel biomarker test methods is expected to surge the growth of the rheumatoid arthritis diagnosis test market.

However, factors such as limited specificity and sensitivity of rheumatoid arthritis diagnosis test kits and lack of effective drug treatment are projected to deter the growth of the rheumatoid arthritis diagnosis test market.

Key Segments of Rheumatoid Arthritis Diagnosis Test Market

PMR’s study on the rheumatoid arthritis diagnosis test market offers information divided into four important segments— diagnostic test type, end user, and region. This report offers comprehensive data and information about the important market dynamics, and growth parameters associated with these categories.

Diagnostic Test Type
  • Serology Tests
    • Erythrocyte Sedimentation Rate (ESR) through lens Loupes
    • Rheumatoid Factor (RF)
    • Anti–cyclic Citrullinated Peptide (anti–CCP)
    • Antinuclear Antibody (ANA)
    • Uric Acid
    • Other Tests
  • Monitoring RA Treatment Efficiency Tests
    • Salicylate Level Count
    • Muscle Enzyme Tests
    • Creatinine Test
End User
  • Hospitals
  • Diagnostic Laboratories
    • Private Laboratories
    • Public Laboratories
  • Ambulatory Surgical Centers
Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Key Questions Answered in PMR’s Rheumatoid Arthritis Diagnosis Test Market Report

  • Which regions will continue to remain the most profitable regional markets for rheumatoid arthritis diagnosis test market players?
  • Which factors will induce a change in the demand for rheumatoid arthritis diagnosis test in the assessment period?
  • How will changing trends impact the rheumatoid arthritis diagnosis test market?
  • How can market players capture the low-hanging opportunities in the rheumatoid arthritis diagnosis test in developed regions?
  • Which companies are leading the rheumatoid arthritis diagnosis test market?
  • What are the winning strategies of stakeholders in the rheumatoid arthritis diagnosis test market to upscale their position in this landscape?

Media Release

Recommendations

Advanced Medical Nutrition Market

Global Advanced Medical Nutrition Market - explore share, size, revenue, valuation, CAGR, regional outlook, key players, competitive landscape & projections.

Western Blotting Market

Western Blotting Market is slated to reach a valuation of US$ 725 Mn in 2021 end, reflecting a CAGR of 5.9% during the period of forecast 2017-2021..

Peptone Market

Peptone Market is expected to boost demand in biotechnology research due to it rapid growth in 2030..

Artificial Vital Organs and Medical Bionics Market

The artificial vital organs and medical bionics market is expected to expand from US$ 46.4 billion in 2022 to US$ 107.4 billion in 2032. Previously, the market grew at a faster rate of 9.6% from 2015 to 2021, culminating in a market of US$ 42.4 billion in 2021..

Our Clients

Our Clients